GB201309960D0 - Novel pyrrole derivatives - Google Patents

Novel pyrrole derivatives

Info

Publication number
GB201309960D0
GB201309960D0 GBGB1309960.1A GB201309960A GB201309960D0 GB 201309960 D0 GB201309960 D0 GB 201309960D0 GB 201309960 A GB201309960 A GB 201309960A GB 201309960 D0 GB201309960 D0 GB 201309960D0
Authority
GB
United Kingdom
Prior art keywords
pyrrole derivatives
novel pyrrole
novel
derivatives
pyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1309960.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Priority to GBGB1309960.1A priority Critical patent/GB201309960D0/en
Publication of GB201309960D0 publication Critical patent/GB201309960D0/en
Priority to PCT/GB2014/051728 priority patent/WO2014195705A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
GBGB1309960.1A 2013-06-04 2013-06-04 Novel pyrrole derivatives Ceased GB201309960D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1309960.1A GB201309960D0 (en) 2013-06-04 2013-06-04 Novel pyrrole derivatives
PCT/GB2014/051728 WO2014195705A1 (en) 2013-06-04 2014-06-04 Novel pyrrole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1309960.1A GB201309960D0 (en) 2013-06-04 2013-06-04 Novel pyrrole derivatives

Publications (1)

Publication Number Publication Date
GB201309960D0 true GB201309960D0 (en) 2013-07-17

Family

ID=48805732

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1309960.1A Ceased GB201309960D0 (en) 2013-06-04 2013-06-04 Novel pyrrole derivatives

Country Status (2)

Country Link
GB (1) GB201309960D0 (en)
WO (1) WO2014195705A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201708457D0 (en) * 2017-05-26 2017-07-12 Univ Oxford Innovation Ltd Inhibitors of metallo-beta-lactamases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324747A (en) * 1992-07-15 1994-06-28 Hoffmann-La Roche Inc. N-substituted anilines, inhibitors of phospholipases A2
WO1997047299A1 (en) * 1996-06-12 1997-12-18 3-Dimensional Pharmaceuticals, Inc. Amidino and guanidino heterocyclic protease inhibitors
WO2006020004A2 (en) * 2004-07-19 2006-02-23 Merck & Co., Inc. Histone deacetylase inhibitors
CL2007002097A1 (en) * 2006-07-20 2008-01-18 Smithkline Beecham Corp Compounds derived from pyrrolidine or morpholine antagonists of urotensin ii; pharmaceutical composition comprising said compounds; and its use to treat congestive heart failure, ischemic heart failure, angina, myocardial ischemia, overactive bladder, asthma and / or copd, among others.
EP2602248A1 (en) * 2011-12-05 2013-06-12 University Of Leicester Novel pyrrole compounds

Also Published As

Publication number Publication date
WO2014195705A1 (en) 2014-12-11

Similar Documents

Publication Publication Date Title
HK1215795A1 (en) Amatoxin derivatives
HRP20170919T1 (en) Novel pyrazol derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
AP2015008636A0 (en) Substituted imidazopyridazines
AP2016009025A0 (en) Substituted pyrazolo-pyridinamines
SG11201605189YA (en) Imidazopyrazinone derivatives
AP2016009303A0 (en) Substituted piperidinyl-tetrahydroquinolines
HK1213566A1 (en) Novel tetrazolone derivatives
GB201309960D0 (en) Novel pyrrole derivatives
GB201309935D0 (en) Novel pyrrole derivatives
EP3009444A4 (en) Alpha-oxoacyl amino-caprolactam derivative
GB201310126D0 (en) Novel pyrrole derivatives
GB201309934D0 (en) Novel pyrrole derivatives
GB201309959D0 (en) Novel pyrrole derivatives
GB201309932D0 (en) Novel pyrrole derivative
GB201300649D0 (en) Cyclization
GB201314960D0 (en) Heterocyclic derivatives
GB201300306D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)